Schedule of Restricted Stock Award Activity (Details) - $ / shares		9 Months Ended		12 Months Ended
		Sep. 30, 2022		Dec. 31, 2021
2014 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested restricted stock, shares		100,000		100,000
2014 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance		1,666,666
Weighted Average Grant Date Fair Value, Outstanding, Beginning Balance		$ 2.36
Number of Stock Options, Granted	[1]
Weighted Average Grant Date Fair Value, Granted	[1]
Number of Stock Options, Vested		(541,666)
Weighted Average Grant Date Fair Value, Vested		$ 1.20
Number of Stock Options, Forfeited		(150,000)
Weighted Average Grant Date Fair Value, Forfeited		$ 2.04
Number of Stock Options Outstanding, Ending Balance		975,000	[1]	1,666,666
Weighted Average Grant Date Fair Value, Outstanding, Ending Balance		$ 3.05	[1]	$ 2.36
Number of Stock Options, Forfeited		150,000
2018 Equity Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unvested restricted stock, shares		50,000		50,000
2018 Equity Plan [Member] | Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Stock Options Outstanding, Beginning Balance		1,940,740
Weighted Average Grant Date Fair Value, Outstanding, Beginning Balance		$ 12.76
Number of Stock Options, Granted		320,000
Weighted Average Grant Date Fair Value, Granted		$ 4.53
Number of Stock Options, Vested		(169,320)
Weighted Average Grant Date Fair Value, Vested		$ 13.48
Number of Stock Options, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Stock Options Outstanding, Ending Balance		2,091,420		1,940,740
Weighted Average Grant Date Fair Value, Outstanding, Ending Balance		$ 11.44		$ 12.76
Number of Stock Options, Forfeited

[1] The unvested restricted stock awards presented in the table above, are inclusive of 100,000 restricted stock awards granted outside the PAVmed Inc. 2014 Equity Plan as of September 30, 2022 and December 31, 2021.